HBx protein induces expression of MIG and increases migration of leukocytes through activation of NF-κB

Virology

Volumn 385, Issue 2, 2009, Pages 335-342

  Xia, Li Min ^a   Huang, Wen Jie ^a,b   Wu, Jian Guo ^c   Yang, Yong Bo ^c   Zhang, Qiong ^a   Zhou, Zhen Zhen ^a   Zhu, Hui Fen ^a   Lei, Pin ^a   Shen, Guan Xin ^a   Tian, De An ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

HBV; HBx; MIG; Migration; NF B; Promoter

Indexed keywords

CXCL9 CHEMOKINE; HEPATITIS B VIRUS X PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LEUKOCYTE MIGRATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TRANSCRIPTION INITIATION; UPREGULATION;

BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CHEMOKINE CXCL9; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN TRANSPORT; TRANS-ACTIVATORS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

HEPATITIS B VIRUS;

EID: 60649090597     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.11.042     Document Type: Article

References (39)

1. Ando K., Guidotti L.G., Wirth S., Ishikawa T., Missale G., Moriyama T., Schreiber R.D., Schlicht H.J., Huang S.N., and Chisari F.V. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152 (1994) 3245-3253
2. Asensio V., and Campbell I. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J. Virol. 71 (1997) 7832-7840
3. Bieche I., Asselah T., Laurendeau I., Vidaud D., Degot C., Paradis V., Bedossa P., Valla D.C., Marcellin P., and Vidaud M. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virol. 332 (2005) 130-144
4. Borgland S.L., Bowen G.P., Wong N.C., Libermann T.A., and Muruve D.A. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB. J. Virol. 74 (2000) 3941-3947
5. Bouchard M.J., and Schneider R.J. The enigmatic X gene of hepatitis B virus. J. Virol. 78 (2004) 12725-12734
6. Bouchard M.J., Wang L., and Schneider R.J. Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J. Virol. 80 (2006) 4406-4414
7. Chen L.F., and Greene W.C. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5 (2004) 392-401
8. Chisari F.V., and Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13 (1995) 29-60
9. Cougot D., Wu Y., Cairo S., Caramel J., Renard C.A., Lévy L., Buendia M.A., and Neuveut C. The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J. Biol. Chem. 282 (2007) 4277-4287
10. Diao J., Garces R., and Richardson C.D. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev. 12 (2001) 189-205
11. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
12. Horton M.R., McKee C.M., Bao C., Liao F., Farber J.M., Hodge-DuFour J., Puré E., Oliver B.L., Wright T.M., and Noble P.W. Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J. Biol. Chem. 273 (1998) 35088-35094
13. Horton M.R., Boodoo S., and Powell J.D. NF-kappa B activation mediates the cross-talk between extracellular matrix and interferon-gamma (IFN-gamma) leading to enhanced monokine induced by IFN-gamma (MIG) expression in macrophages. J. Biol. Chem. 277 (2002) 43757-43762
14. Ishiguro N., Takada A., Yoshioka M., Ma X., Kikuta H., Kida H., and Kobayashi K. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Arch. Virol. 149 (2004) 17-34
15. Kakimi K., Lane T.E., Wieland S., Asensio V.C., Campbell I.L., Chisari F.V., and Guidotti L.G. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J. Exp. Med. 194 (2001) 1755-1766
16. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu. Rev. Immunol. 18 (2000) 621-663
17. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2 (2002) 301-310
18. Kin Y., and Fischer S.M. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J. Biol. Chem. 273 (1998) 27686-27694
19. Kutsch O., Oh J., Nath A., and Benveniste E.N. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74 (2000) 9214-9221
20. Liao F., Rabin R.L., Yannelli J.R., Koniaris L.G., Vanguri P., and Farber J.M. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182 (1995) 1301-1314
21. Loetscher M., Gerber B., Leotscher P., Jones S.A., Piali L., Clark-Lewis I., Baggiolini M., and Moser B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184 (1996) 963-969
22. Lufitg M., Yasui T., Soni V., Kang M.S., Jacobson N., Cahir-McFarland E., Seed B., and Kieff E. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 141-146
23. Luster A.D. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14 (2002) 129-135
24. Maini M.K., Boni C., Lee C.K., Larrubia J.R., Reignat S., Ogg G.S., King A.S., Herberg J., Gilson R., Alisa A., Williams R., Vergani D., Naoumov N.V., Ferrari C., and Bertoletti A. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191 (2000) 1269-1280
25. Malek S., Huxford T., and Ghosh G. Ikappa Balpha functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-kappaB. J. Biol. Chem. 273 (1998) 25427-25435
26. Miyamoto S., and Verma I.M. Rel/NF-kappa B/I kappa B story. Adv. Cancer Res. 66 (1995) 255-292
27. Moon E.J., Jeong C.H., Jeong J.W., Kim K.R., Yu D.Y., Murakami S., Kim C.W., and Kim K.W. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J. 18 (2004) 382-384
28. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J. Gastroenterol. 36 (2001) 651-660
29. Romagnani P., Annunziato F., Lasagni L., Lazzeri E., Beltrame C., Francalanci M., Uguccioni M., Galli G., Cosmi L., Maurenzig L., Baggiolini M., Maggi E., Romagnani S., and Serio M. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107 (2001) 53-63
30. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18 (2000) 217-242
31. Schmitz M.L., and Baeuerle P.A. Multi-step activation of NF-kappa B/Rel transcription factors. Immunobiology 193 (1995) 116-127
32. Shahabuddin S., Ji R., Wang P., Brailoiu E., Dun N., Yang Y., Aksoy M.O., and Kelsen S.G. CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. Am. J. Physiol. Cell Physiol. 291 (2006) C34-C39
33. Simeonidis S., Stauber D., Chen G., Hendrickson W.A., and Thanos D. Ikappa Balpha functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-kappaB. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 49-54
34. Sitia G., Isogawa M., Kakimi K., Wieland S.F., Chisari F.V., and Guidotti L.G. Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13717-13722
35. Strieter R.M., Polverini P.J., Arenberg D.A., and Kunkel S.L. The role of CXC chemokines as regulators of angiogenesis. Shock 4 (1995) 155-160
36. Summers J., O'Connell A., and Millman I. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 4597-4601
37. Takenaka M., Preston A.S., Kwon H.M., and Handler J.S. The tonicity-sensitive element that mediates increased transcription of the betaine transporter gene in response to hypertonic stress. J. Biol. Chem. 269 (1994) 29379-29381
38. Zhang X., Wu K.L., Wang D., Yue X., Song D.G., Zhu Y., and Wu J.G. Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-κB. Virology 365 (2007) 324-335
39. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127